336 related articles for article (PubMed ID: 2227068)
21. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
Hausmann L; Goebel KM; Zehner J
Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
[TBL] [Abstract][Full Text] [Related]
22. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
[TBL] [Abstract][Full Text] [Related]
23. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
24. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
Miller JF; Fotherby K; Bye PG; Elstein M
Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
[TBL] [Abstract][Full Text] [Related]
25. Clinical studies with a low dose estrogen-progestogen combination.
Sartoretto JN; Ortega-Recio JC; Moraes R; Filho FN
Contraception; 1977 May; 15(5):563-70. PubMed ID: 880827
[TBL] [Abstract][Full Text] [Related]
26. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol.
Kubba AA; White JO; Guillebaud J; Elder MG
Fertil Steril; 1986 Apr; 45(4):512-6. PubMed ID: 3956767
[TBL] [Abstract][Full Text] [Related]
27. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
[TBL] [Abstract][Full Text] [Related]
28. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
29. Postcoital contraception: How effective and what fetal risk, if ineffective??
Proudfit CM
JAMA; 1977 Dec; 238(25):2728-9. PubMed ID: 12260335
[TBL] [Abstract][Full Text] [Related]
30. Post-coital contraception using d1-norgestrel/ethinyl estradiol combination.
Smith RP; Ross A
Contraception; 1978 Mar; 17(3):247-52. PubMed ID: 648149
[TBL] [Abstract][Full Text] [Related]
31. [Danazol: a new hormonal post-coital contraceptive method].
Colombo U; Zuliani G; Molla R; Santini F; Santarone MA; Benzi G
Contracept Fertil Sex (Paris); 1986 Feb; 14(2):131-5. PubMed ID: 12267799
[TBL] [Abstract][Full Text] [Related]
32. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
Klove KL; Roy S; Lobo RA
Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
[TBL] [Abstract][Full Text] [Related]
33. A reassessment of efficacy of the Yuzpe regimen of emergency contraception.
Creinin MD
Hum Reprod; 1997 Mar; 12(3):496-8. PubMed ID: 9130749
[TBL] [Abstract][Full Text] [Related]
34. [Post-coital contraception].
Serfaty D
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207
[TBL] [Abstract][Full Text] [Related]
35. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
36. Effect of low-dose progestogen-estrogen combination (WL-20) on the menstrual cycle of sexually active women of childbearing age.
Sartoretto JN; Moraes R
Contraception; 1974 Aug; 10(2):127-34. PubMed ID: 4418507
[TBL] [Abstract][Full Text] [Related]
37. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
Nilsson S; Nygren KG; Johansson ED
Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
[TBL] [Abstract][Full Text] [Related]
38. A low-dose triphasic oral contraceptive.
Woutersz TB; Butler AJ; Cohen M; Korba VD; Canavan RC
Fertil Steril; 1987 Mar; 47(3):425-30. PubMed ID: 3556622
[TBL] [Abstract][Full Text] [Related]
39. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
